IC
IBIO icon

Ikarian Capital’s iBio IBIO Stock Holding History

Ikarian Capital’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Hold
957,062
– – 0.18% 93
2026
Q1 		$1.82M Hold
957,062
– – 0.15% 102
2025
Q4 		$1.85M Buy
957,062
+339,735
+55% +$464K 0.14% 105
2025
Q3 		$511K Buy
617,327
+17,414
+3% +$13.4K 0.05% 137
2025
Q2 		$458K Hold
599,913
– – 0.09% 93
2025
Q1 		$2.41M Hold
599,913
– – 0.3% 65
2024
Q4 		$1.47M Sell
599,913
-87
-0% -$224 0.2% 93
2024
Q3 		$1.33M Hold
600,000
– – 0.19% 86
2024
Q2 		$1.27M Hold
600,000
– – 0.22% 65
2024
Q1 		$2.44M Buy
+600,000
New +$754K 0.27% 81

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Ikarian Capital's IBIO Position: Q2 2026 in Review

Ikarian Capital held its iBio (IBIO) position steady in Q2 2026 at 957,062 shares worth $1.67M. The position accounts for 0.18% of the portfolio, ranked #93.

Ikarian Capital first reported a position in IBIO in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.44M in Q1 2024. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Ikarian Capital held 957,062 shares of iBio worth $1.67M as of Q2 2026.
  • Ikarian Capital left its iBio share count unchanged in Q2 2026.
  • iBio made up 0.18% of Ikarian Capital's portfolio in Q2 2026, its #93 holding.
  • Ikarian Capital first reported a position in iBio in Q1 2024 and has held it in 10 quarters since.
  • Ikarian Capital's iBio position peaked at $2.44M in Q1 2024.
  • 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.